SHARONBIO — Sharon Bio-Medicine Share Price
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 7.49% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 8,384.65 | 2,534.55 | 1,728.62 | 1,883.91 | 1,949.79 | n/a | n/a | -31.83% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +25.81 | +7.52 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sharon Bio-Medicine Limited is an India-based pharmaceutical company. The Company is engaged in providing a range of pharmaceutical products and services, including animal toxicology and manufacturing of finished dosages. The Company's products include active pharma ingredients (APIs) and intermediates, and formulations. Its APIs and intermediates include Ketoconazole, Miconazole Nitrate, Sertaconazole Nitrate, Trimetazidine Di HCl, Nifedipine, Atomoxetine HCl, Trazodone HCl, Memantine HCI, Eperisone HCl, Glimepiride, Mosapride Citrate Dihydrate and Aripiprazole. Its formulation includes Aripiprazole tablets, Atorvastatin tablets, Azithromycin tablets, Betahistine tablets, Carbimazole tablets, Celecoxib capsules, Clopidogrel tablets, Carbocisteine capsules, Enalapril Maleate tablets, Donepezil tablets, Ezetimibe tablets and Famciclovir tablets. Its manufacturing facility is located at Navi Mumbai.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- March 31st, 2023
- Incorporated
- June 19th, 1989
- Public Since
- March 22nd, 2000
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 5,755,625
- Address
- 601, NAVI MUMBAI, 400705
- Web
- https://www.sharonbio.com/
- Phone
- +91 2267944000
- Auditors
- Shyam C. Agrawal & Co.
Upcoming Events for SHARONBIO
Similar to SHARONBIO
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Sharon Bio-Medicine share price?
As of Today at 18:19 UTC, shares in Sharon Bio-Medicine are trading at IN₹3.30. This share price information is delayed by 15 minutes.
How has the Sharon Bio-Medicine share price performed this year?
Shares in Sharon Bio-Medicine last closed at IN₹3.30 and the price had moved by -40% over the past 365 days. In terms of relative price strength the Sharon Bio-Medicine share price has underperformed the S&P BSE 100 Index by -52.02% over the past year.
What are the analyst and broker recommendations for Sharon Bio-Medicine?
There is no consensus recommendation for this security.
Find out moreWhat is the Sharon Bio-Medicine dividend yield?
Sharon Bio-Medicine does not currently pay a dividend.
Does Sharon Bio-Medicine pay a dividend?
Sharon Bio-Medicine does not currently pay a dividend.
When does Sharon Bio-Medicine next pay dividends?
Sharon Bio-Medicine does not currently pay a dividend.
How do I buy Sharon Bio-Medicine shares?
To buy shares in Sharon Bio-Medicine you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sharon Bio-Medicine?
As of the previous close price of IN₹3.30, shares in Sharon Bio-Medicine had a market capitalisation of .
Where are Sharon Bio-Medicine shares listed?
Here are the trading details for Sharon Bio-Medicine:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SHARONBIO
What kind of share is Sharon Bio-Medicine?
Based on an overall assessment of its quality, value and momentum Sharon Bio-Medicine is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sharon Bio-Medicine share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sharon Bio-Medicine share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sharon Bio-Medicine. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -37.77%.
As of the last closing price of IN₹3.30, shares in Sharon Bio-Medicine were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sharon Bio-Medicine PE Ratio?
The Sharon Bio-Medicine PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹3.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sharon Bio-Medicine?
Sharon Bio-Medicine's management team is headed by:
- Kaushik Banerjee - CEO